United Therapeutics Corp (UTHR)

07:43 AM

H.C. Wainwright lowers United Therapeutics stock price target on Tyvaso competition concerns - Investing.com Nigeria

07:43 AM

03:00 AM

United Therapeutics Corp (UTHR) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic ... By GuruFocus - Investing.com Canada

03:00 AM

01:19 AM

United Therapeutics: Q2 Earnings Snapshot - Greenwich Time

01:19 AM

12:28 PM

United Therapeutics Reports Record Q2 2025 Financial Results - TipRanks

12:28 PM

12:08 PM

Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insight - GuruFocus

12:08 PM

Jul 30, 2025

United Therapeutics’ Phase 3 Study on Inhaled Treprostinil: A Potential Game-Changer for IPF Treatment - TipRanks

Jul 30, 2025

Jul 30, 2025

United Therapeutics Stock Slides On Q2 Earnings: The Details - 富途牛牛

Jul 30, 2025

Jul 30, 2025

Earnings call transcript: United Therapeutics Q2 2025 misses EPS, stock drops - Investing.com

Jul 30, 2025

Jul 30, 2025

United Therapeutics’ Promising Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis - TipRanks

Jul 30, 2025

Jul 30, 2025

Compared to Estimates, United Therapeutics (UTHR) Q2 Earnings: A Look at Key Metrics - Nasdaq

Jul 30, 2025

Jul 30, 2025

United Therapeutics Q2 2025 slides: Revenue up 12% as Tyvaso drives growth - Investing.com India

Jul 30, 2025

Jul 30, 2025

United Therapeutics Q2 2025 slides: Revenue up 12% as Tyvaso drives growth By Investing.com - Investing.com South Africa

Jul 30, 2025

Jul 30, 2025

United Therapeutics Logs Growth And Launches Big Buyback - Finimize

Jul 30, 2025

Jul 30, 2025

United Therapeutics misses Q2 earnings expectations - Investing.com

Jul 30, 2025

Jul 30, 2025

United Therapeutics Corporation Reports Record Second Quarter 2025 Financial Results - TradingView

Jul 30, 2025

Jul 30, 2025

UNITED THERAPEUTICS Corp SEC 10-Q Report - TradingView

Jul 30, 2025

Jul 30, 2025

United Therapeutics earnings missed by $0.94, revenue fell short of estimates - Investing.com

Jul 30, 2025

Jul 30, 2025

United Therapeutics Delivers Triple Win: Record $799M Revenue, $1B Buyback, and Major Pipeline Progress - Stock Titan

Jul 30, 2025

Jul 29, 2025

United Therapeutics Corporation (UTHR) Launches First UKidney Human Trial - MSN

Jul 29, 2025

Jul 29, 2025

United Therapeutics’ Promising IPF Treatment Study: A Market Game-Changer? - The Globe and Mail

Jul 29, 2025

Jul 29, 2025

Preview: United Therapeutics's Earnings - 富途牛牛

Jul 29, 2025

Jul 29, 2025

Bleecker Street Research short United Therapeutics, long Liquidia - TipRanks

Jul 29, 2025

Jul 29, 2025

United Therapeutics Earnings Announcement and Market OutlookNews and Statistics - IndexBox

Jul 29, 2025

Jul 29, 2025

Is There Enough Volume to Lift United Therapeutics CorporationTriple Return Setup With Risk Control Explained - metal.it

Jul 29, 2025

Jul 29, 2025

UBS Trims Price Target but Stays Bullish on United Therapeutics (UTHR) - MSN

Jul 29, 2025

Jul 29, 2025

Why United Therapeutics Corporation stock attracts strong analyst attentionWeekly Top Gainers Forecast Watchlist Released - metal.it

Jul 29, 2025

Jul 29, 2025

What institutions are buying United Therapeutics Corporation stock nowEarnings Play Trade Plan With Alerts Shared - metal.it

Jul 29, 2025

Jul 28, 2025

What To Expect From United Therapeutics’s (UTHR) Q2 Earnings - Yahoo.co

Jul 28, 2025

Jul 28, 2025

ROSEN, A LEADING LAW FIRM, Encourages 3D Systems Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

Jul 28, 2025

Jul 28, 2025

How many analysts rate United Therapeutics Corporation as a “Buy”Entry Signal Forecasts With Low Risk - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

United Therapeutics’ Inhaled Treprostinil Study: A Potential Game-Changer for Pulmonary Fibrosis - TipRanks

Jul 28, 2025

Jul 28, 2025

How volatile is United Therapeutics Corporation stock compared to the marketStay informed with daily expert analysis - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

Leerink Partners Remains a Buy on United Therapeutics Corporation (UTHR) With a $408 PT - Insider Monkey

Jul 28, 2025

Jul 28, 2025

What are the technical indicators suggesting about United Therapeutics CorporationRapid-fire capital growth - jammulinksnews.com

Jul 28, 2025

Jul 27, 2025

When is United Therapeutics Corporation stock expected to show significant growthHigh-performance stocks for savvy investors - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

Is United Therapeutics Corporation stock overvalued or undervaluedHigh-yield portfolio picks - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

What makes United Therapeutics Corporation stock price move sharplyGet expert analysis on top stock picks - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

What are the latest earnings results for United Therapeutics CorporationExplosive returns - jammulinksnews.com

Jul 27, 2025

Jul 26, 2025

United Therapeutics EVP Mahon sells $3.3m in shares By Investing.com - Investing.com India

Jul 26, 2025

Jul 26, 2025

United Therapeutics EVP Mahon sells $3.3m in shares - Investing.com

Jul 26, 2025

Jul 25, 2025

10 Most Profitable Biotech Stocks to Invest in Now - Insider Monkey

Jul 25, 2025

Jul 25, 2025

META_TITLE_SECTORS - Yahoo Finance

Jul 25, 2025

Jul 25, 2025

United Therapeutics Corporation Stock Analysis and ForecastRapid market gains - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

TD Cowen maintained a Buy rating on United Therapeutics (UTHR), Kept the PT Unchanged - Insider Monkey

Jul 25, 2025

Jul 24, 2025

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages 3D Systems Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

Jul 24, 2025

Jul 24, 2025

Pulmonary Arterial Hypertension Drug Market Set for Strong - openPR.com

Jul 24, 2025

Jul 24, 2025

United Therapeutics (UTHR) Crossed Above the 50-Day Moving Average: What That Means for Investors - Yahoo Finance

Jul 24, 2025